Skip to main content
CBZ
NYSE Trade & Services

CBIZ Q2 Earnings Plunge 56%, Material Weaknesses Disclosed, Guidance Pulled Amid $5B Buyout

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Business Services Stocks · Industrial
Sentiment info
Negative
Importance info
9
Price
$55.08
Mkt Cap
$2.955B
52W Low
$24.29
52W High
$67.24
52W Position info
127% above low
Off High info
18% below high
Rel. Volume info
1.8× avg
Market data snapshot near publication time

CBZ has more than doubled off its 52-week low of $24.29.

Summary

CBIZ reported a 55.6% drop in Q2 net income, withdrew 2026 guidance, and disclosed two material weaknesses in internal controls, including a restatement of Q1 results. The filing comes amid a pending $5 billion all-cash acquisition at $55.00 per share.


Key Events · Earnings and Guidance · CBZ

  • Q2 Net Income Plunges 55.6%

    Net income fell to $18.6 million from $41.9 million a year ago, driven by higher operating expenses and a $7.2 million legal settlement loss.

  • 2026 Guidance Withdrawn

    Management pulled its full-year outlook, citing uncertainty related to the pending acquisition by Grant Thornton Advisors.

  • Two Material Weaknesses Disclosed

    The company identified material weaknesses in internal controls over ESPP share administration and goodwill reassignment, leading to a restatement of Q1 2026 results.

  • $57.2M Gain from Marcum Working Capital Adjustment

    A one-time gain from finalizing the Marcum acquisition working capital partially offset the earnings decline.


Analysis · CBZ · Trade & Services

CBIZ's Q2 2026 10-Q reveals a sharp 55.6% drop in net income to $18.6 million, driven by higher operating costs and a $7.2 million legal settlement. The company withdrew its full-year 2026 guidance, citing uncertainty from the pending $55/share acquisition by Grant Thornton. Critically, management disclosed two material weaknesses in internal controls — one related to an ESPP share over-issuance that forced a restatement of Q1 results, and another involving goodwill reassignment. These control failures, combined with the earnings miss and guidance pull, raise serious governance concerns even as the all-cash buyout at $55.00 per share provides a floor for the stock.

At the time of this filing, CBZ was trading at $55.08 on NYSE in the Trade & Services sector, with a market capitalization of approximately $3B. The 52-week trading range was $24.29 to $67.24. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CBZ - Latest Insights

CBZ
Aug 04, 2026, 4:45 PM EDT
Filing Type: 10-K/A
Importance Score:
8
Price at Filing: $55.08
Real-time Price: $55.08 info
Change: $0 (0%) info
Market Cap: $2.973B info
CBZ
Jul 29, 2026, 8:18 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $54.50
Real-time Price: $55.08 info
Change: +$0.580 (+1%) info
Market Cap: $2.973B info
CBZ
Jul 29, 2026, 8:16 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $46.70
Real-time Price: $55.08 info
Change: +$8.38 (+18%) info
Market Cap: $2.973B info
CBZ
Jul 29, 2026, 8:12 AM EDT
Filing Type: 8-K
Importance Score:
10
Price at Filing: $46.70
Real-time Price: $55.08 info
Change: +$8.38 (+18%) info
Market Cap: $2.973B info
CBZ
Jul 29, 2026, 8:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $46.70
Real-time Price: $55.08 info
Change: +$8.38 (+18%) info
Market Cap: $2.973B info